Calcitriol attenuates liver fibrosis through hepatitis C virus nonstructural protein 3-transactivated protein 1-mediated TGF β1/Smad3 and NF-κB signaling pathways
CONCLUSION: Our results suggest that calcitriol may be employed as an adjuvant therapy for hepatic fibrosis and that NS3TP1 is a unique, prospective therapeutic target in hepatic fibrosis.PMID:37274069 | PMC:PMC10237113 | DOI:10.3748/wjg.v29.i18.2798
Source: World Journal of Gastroenterology : WJG - Category: Gastroenterology Authors: Liu Shi Li Zhou Ming Han Yu Zhang Yang Zhang Xiao-Xue Yuan Hong-Ping Lu Yun Wang Xue-Liang Yang Chen Liu Jun Wang Pu Liang Shun-Ai Liu Xiao-Jing Liu Jun Cheng Shu-Mei Lin Source Type: research
More News: Gastroenterology | Hepatitis | Hepatitis C | Liver | Statistics | Students | Study | Universities & Medical Training | Urology & Nephrology